Infectious disease

Across all of St. David’s HealthCare hospitals, infectious disease research is comprised of an interdisciplinary team led by our involving infectious disease medical directors. Key team members and departments include treating physicians (cardiovascular, pulmonary), unit nurses, hospital pharmacy, laboratory department, and information technology. We have clinical studies around:

• Patients who are experiencing symptoms of COVID-19 or diagnosed with COVID-19
• Patients who require respiratory therapy including ventilation therapy
• Novel nucleotide antivirals, antibodies, antigens, and vaccines
• Oral, injection, and IV infusion therapies
• Many studies are to prevent severe immune response cytokine inflammatory storm events
• Some studies are to provoke a safe immune response while others are for treatment
• Studies are also focused on reducing related complications including pulmonary and cardiovascular complications

Our infectious disease physician researchers and their colleagues across several St. David’s hospitals and departments examine which studies can be most helpful to advance science, clinical care, and improve patient outcomes from a myriad of potential sponsored studies. Moreover, multiple clinical evaluation studies are around:

• Evaluating the safety and efficacy of novel and repurposed medications and devices
• Studies are focused on patients who are experiencing localized or systemic infectious diseases
• Risk factors associated with infection and methods to reduce and eliminate infection brought to the hospital by patients as well as reduce any hospital-acquired infections
• Studies involve a multitude of prevention strategies and surgical site infections whether for cardiovascular, orthopedic, spine, neonatal, and brain